title: Sleep disturbance of end-stage renal disease.
abstract: Sleep disturbance of patients with end-stage renal disease was examined in a sample of 127 patients receiving hemodialysis (HD) therapy. The results indicate that sleep disturbance occurs quite often. Especially, there was a high incidence of sleep disturbance with prolonged HD therapy and with advancing age, and that somatic complications due to long-term HD indirectly influence sleep disturbance. On the effect of drug therapy, levodopa produced significant clinical effects on RLS compared to ordinary hypnotics. Carbamazepine equally tended to produce favorable clinical effects on RLS.
authors.affiliation: Department of Psychiatry, Sagamidai Hospital, Sagami, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Yoshioka
authors.forename: T
authors.initials: T
authors.lastname: Ishii
authors.forename: I
authors.initials: I
authors.lastname: Fukunishi
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000503:physiopathology* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D006435:Renal Dialysis; D012803:Sick Role; D007319:Sleep Initiation and Maintenance Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology / Q000523:psychology; D012893:Sleep Wake Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology* / Q000523:psychology
chemical_list: D006993:Hypnotics and Sedatives